Wellington Management Group LLP 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-13 4:05 pm Sale | 2026-06-30 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Wellington Management Group LLP | 0 0.000% | -4,426,781 (Position Closed) | Filing |
| 2026-05-15 07:06 am Purchase | 2026-03-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Wellington Management Group LLP | 4,426,781 8.600% | 1,103,982 (+33.22%) | Filing |
| 2026-02-10 11:17 am Purchase | 2025-12-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Wellington Management Group LLP | 3,322,799 6.200% | 3,322,799 (New Position) | Filing |